Comparison of treatment status of patients with acute heart failure before and after the spread of COVID19 infection

Comparison of treatment status of patients with acute heart failure before and after the spread of COVID19 infection (Cohort observational study using DPC data) - Comparison of treatment status of patients with acute heart failure before and after the spread of COVID19 infection

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051595

Enrollment

5000

Registered

2023-08-10

Start date

2022-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COVID-19 during each enrollment period before and after the declaration of an emergency,the name of injury or illness that triggered hospitalization was heart failure(see Table 8-5) and the patient was admitted to the emergency medical care hospital (the same patient was present).If so, give priority to the first hospitalization)

Exclusion criteria

Exclusion criteria: - Patients under the age of 18 as of Index Date. - Patients undergoing dialysis within 2 days after admission. - Patients with COVID-19 diagnosis (ICD-10: U07.1 COVID19 virus, identified) from 1 year before admission to the date of discharge. - Patients with a diagnosis of respiratory infection (tonsillitis, upper respiratory tract inflammation, influenza, viral pneumonia, pneumonia, aspiration pneumonia, etc.) at the time of admission. - Patients with "acute respiratory distress syndrome (J80)", "end-stage renal failure (N185)", "cardiopulmonary arrest at admission (I469)" at admission.

Design outcomes

Primary

Measure	Time frame
-Implementation of NPPV	—

Secondary

Measure	Time frame
- Hospitalization period - In-hospital death - Implementation of tracheal intubation	—

Countries

Japan

Contacts

Public ContactMiyuki Matsukawa

Otsuka Pharmaceutical Co., Ltd. Medical Affairs

matsukawa.miyuki@otsuka.jp08067917646

Outcome results